Almirall News
Most Popular Almirall Story
Forest, Almirall delay NDA, plan new studies
Forest Laboratories and Spain's Almirall say that a planned NDA filing for their new COPD drug will be delayed for an uncertain amount of time after the FDA made it clear that the developers will... Read more...
Latest Headlines
- March 6, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
